Document Detail


Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia.
MedLine Citation:
PMID:  7541549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Benign prostatic hyperplasia (BPH) and hypertension are both common conditions in older men. It is estimated that 20 to 41% of middle-aged to elderly men may have both. Alpha-1 adrenoceptor antagonists, such doxazosin, produce significant improvements in urine flow rate and symptoms in patients with BPH. The effect of doxazosin on urine flow rate and symptoms in hypertensive men with BPH is similar to that seen in normotensive men. By contrast, doxazosin produces a significant fall in blood pressure in hypertensive men, but has minimal effect in normotensives. Doxazosin is well tolerated, irrespective of blood pressure status. Thus, it can be concluded doxazosin is an effective and well tolerated treatment for BPH which appears to have additional benefits in the management of patients with concomitant hypertension.
Authors:
R S Kirby
Related Documents :
10809999 - Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly pa...
1327629 - Disparities in circulatory adjustment to standing between young and elderly subjects ex...
3972249 - Managing geriatric hypertension: a brief review.
1291949 - Modern concepts in endodontics. part 1. diagnosis.
14567499 - Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffne...
16754269 - Findings and implications of the study on cognition and prognosis in the elderly (scope...
12032029 - Pressure support compared with controlled mechanical ventilation in experimental lung i...
17390829 - Brown spot control on pear: infection models versus the inoculum pressure in belgium.
1914479 - Airway pressure release ventilation during acute lung injury: a prospective multicenter...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Scandinavian journal of urology and nephrology. Supplementum     Volume:  168     ISSN:  0300-8886     ISO Abbreviation:  Scand J Urol Nephrol Suppl     Publication Date:  1995  
Date Detail:
Created Date:  1995-08-07     Completed Date:  1995-08-07     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0153034     Medline TA:  Scand J Urol Nephrol Suppl     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  29-33     Citation Subset:  IM    
Affiliation:
St Bartholomew's Hospital, West Smithfield, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Pressure / drug effects*
Doxazosin / therapeutic use*
Humans
Hypertension / complications,  physiopathology*
Male
Middle Aged
Prostatic Hyperplasia / complications,  drug therapy*,  physiopathology
Urodynamics / drug effects
Chemical
Reg. No./Substance:
74191-85-8/Doxazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Profile of doxazosin in patients with benign prostatic hyperplasia.
Next Document:  The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension.